Citius Pharmaceuticals Inc (NASDAQ:CTXR)

1.14
Delayed Data
As of Aug 10
 +0.03 / +2.70%
Today’s Change
0.40
Today|||52-Week Range
1.97
+11.76%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Citius Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +382.46% increase from the last price of 1.14.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Citius Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.11
Sales
$0.00
Reporting Date
Sep 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.55%
 
 
 
 
 
 
Growthannually 37.50%
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.